Science

Real-time nanoscale imaging reveals differences in antibody access to cancer-linked proteins on tiny vesicles

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 16/10/2026, 13:10:24 UTC.

Briefings

Researchers at Kanazawa University's Nano Life Science Institute used high-speed atomic force microscopy to observe antibody interactions with cancer-linked proteins on membrane-bound vesicles. They discovered that protein presence does not equal accessibility, a critical finding for understanding immune evasion in cancer. The study, published in Small Methods, highlights the need for further research before clinical application.

Key points

• High-speed atomic force microscopy was used to observe antibody interactions with cancer-linked proteins on membrane-bound vesicles released by cells.
• The study found that the amount of protein present does not necessarily indicate how accessible it is to antibodies.

Context

This research provides a new method to investigate differences between individual cancer-derived vesicles, addressing a gap in understanding immune evasion mechanisms.

Limitations

Further research is needed before the approach can be used clinically. The study covers only a snapshot of antibody interactions and does not provide causal claims or long-term outcomes.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 16/10/2026, 13:55:48 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeibvvad4w5otu67p3wfov3ehdl34a4a22zvwn4czlnpkviavinunbm